Viewing Study NCT07187869


Ignite Creation Date: 2025-12-24 @ 11:07 PM
Ignite Modification Date: 2025-12-25 @ 8:39 PM
Study NCT ID: NCT07187869
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-23
First Post: 2025-09-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Modulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept Study
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module